Takeda Oncology
Beatriz Ospina is a seasoned scientific researcher currently employed at Takeda Oncology since March 2019. Ospina has extensive experience in the biotechnology and pharmaceutical sectors, having held positions as a Scientist at Sanofi since August 2011, and previously at Novartis Institutes for BioMedical Research (NIBR) from August 2008 to August 2011 as an Associate Scientist. Ospina began a career in cancer research at the Dana-Farber Cancer Institute from May 2005 to August 2008 and worked as a Laboratory Technologist at Charles River Laboratories from August 2001 to May 2005. Ospina earned a Bachelor of Applied Science in Biology from Universidad de Antioquia.
This person is not in any teams
This person is not in any offices
Takeda Oncology
20 followers
In 2008, Takeda Pharmaceutical Company Limited acquired Millennium Pharmaceuticals and the resulting company became exclusively focused on oncology. In 2014, Takeda Oncology was created to become the global headquarters for Takeda’s oncology specialty business unit, in Cambridge, Massachusetts, on the former Millennium Pharmaceuticals site. AtTakeda Oncology they endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients. This singular focus drives our aspirations to discover, develop and deliver breakthrough oncology therapies. By concentrating the power of leading scientific minds and the vast resources of a global pharmaceutical company, they are finding innovative ways to improve the treatment of cancer.They've built a portfolio of paradigm-changing therapies and a leading oncology pipeline. Though They've made great strides in our fight against cancer, they are determined to do more — to work harder and to reach higher. They continue to seek our aspirations with the same passion, agility and entrepreneurial spirit that has sustained our patient-centric culture and has made us the leaders in oncology that they are today.